Berberine is an insulin secretagogue targeting the KCNH6 potassium channel.

6i ) secretion were also higher in the BBR group than in the placebo group, but the differences did not reach statistical significance; this difference might be caused by the previously observed high variability in incremental first phase values 29 .

also in 111,027 other papers